NFX company Mammoth @mammothbiosci, the world's 1st CRISPR-based disease detection platform co-Founded by @martintrevor_, CRISPR pioneer Jennifer Doudna, + others announces a $45 Million Series B to fuel expansion into next-gen therapeutics & gene editing.https://www.nfx.com/post/mammoth-bio-platform-network-effects-gene-editing?utm_source=twitter&utm_campaign=nfxtweet …
0 replies
2 proslijeđena tweeta
18 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.